HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Despite improved transparency, conflicts of interest still arise in medicine
-
- Aromatase inhibitors may prevent mastectomy in some breast cancers
- Forty years of pediatric innovations in oncology: ‘An area of great change’
- HPV testing superior to Pap, safe to extend screening to once every 3 years
- ICU telemedicine intervention decreased mortality, hospital length of stay
- Restrictions on clinical trials impede drug development
- Thorough follow-up of medical history reveals unexpected diagnosis Amit Mehta, MD
- History reveals the future in cancer biography Harry S. Jacob, MD, DHC
- Spread of ovarian carcinoma via lymphatic dissemination Munir Ghesani, MD, FACNM; Gabriel Sara, MD; Amit Patel, MD
-
- Cancer survivorship affected by sexual orientation
- Dactinomycin showed higher complete response rate than methotrexate in low-risk gestational trophoblastic neoplasia
- HHV-6 reactivation linked to central nervous system dysfunction after HCT
- Hypertension potential efficacy biomarker for metastatic renal cell carcinoma
- Life expectancy remains shorter than expected after hematopoietic cell transplantation
- OVA1 test outperformed CA125 for early ovarian cancer detection
- Protein biomarker associated with improved survival in colorectal cancer
- Squamous cell carcinoma antigen linked to high-grade, advanced breast cancer
-
- T-cell levels predicted treatment response in follicular lymphoma
- Topical ISC-4 may help prevent melanoma
- Clopidogrel not associated with excessive post-polypectomy bleeding
- Surgery was strongest predictor for survival in cholangiocarcinoma
- Caring for patients unable to make medical decisions Stephanie M. Harman, MD, FACP